Global Large Volume Wearable Injectors Market Research Report 2023

Large Volume Wearable Injectors, also known as bolus injectors or non-insulin patch pumps, are drug delivery devices that have above 1 ml capacity of injectable volume. These devices can offer a range of benefits to patients, for example, to make administration more convenient and reduce patient suffering.

The global Large Volume Wearable Injectors market was valued at US$ 1471 million in 2022 and is anticipated to reach US$ 11290 million by 2029, witnessing a CAGR of 33.4% during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.

The major players in global Large Volume Wearable Injectors market include Unilife Corporation, BD Medical, etc. The top 2 players occupy about 45% shares of the global market. North America is the main market, and occupies about 70% of the global market. Electronical Injectors is the main type, with a share about 70%. Auto-immune Treatment is the main application, which holds a share about 40%.

This report aims to provide a comprehensive presentation of the global market for Large Volume Wearable Injectors, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Large Volume Wearable Injectors.

The Large Volume Wearable Injectors market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Large Volume Wearable Injectors market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Large Volume Wearable Injectors manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.

1.1 Product Overview and Scope of Large Volume Wearable Injectors

1.2 Large Volume Wearable Injectors Segment by Type

1.2.1 Global Large Volume Wearable Injectors Market Value Comparison by Type (2023-2029)

1.2.2 Electronical Injectors

1.2.3 Mechanical Injectors

1.2.4 Others

1.3 Large Volume Wearable Injectors Segment by Application

1.3.1 Global Large Volume Wearable Injectors Market Value by Application: (2023-2029)

1.3.2 Cancer Treatment

1.3.3 Auto-immune Treatment

1.3.4 Blood Disorders Treatment

1.3.5 Others

1.4 Global Large Volume Wearable Injectors Market Size Estimates and Forecasts

1.4.1 Global Large Volume Wearable Injectors Revenue 2018-2029

1.4.2 Global Large Volume Wearable Injectors Sales 2018-2029

1.4.3 Global Large Volume Wearable Injectors Market Average Price (2018-2029)

1.5 Assumptions and Limitations

2.1 Global Large Volume Wearable Injectors Sales Market Share by Manufacturers (2018-2023)

2.2 Global Large Volume Wearable Injectors Revenue Market Share by Manufacturers (2018-2023)

2.3 Global Large Volume Wearable Injectors Average Price by Manufacturers (2018-2023)

2.4 Global Large Volume Wearable Injectors Industry Ranking 2021 VS 2022 VS 2023

2.5 Global Key Manufacturers of Large Volume Wearable Injectors, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Large Volume Wearable Injectors, Product Type & Application

2.7 Large Volume Wearable Injectors Market Competitive Situation and Trends

2.7.1 Large Volume Wearable Injectors Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Large Volume Wearable Injectors Players Market Share by Revenue

2.7.3 Global Large Volume Wearable Injectors Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3.1 Global Large Volume Wearable Injectors Market Size by Region: 2018 Versus 2022 Versus 2029

3.2 Global Large Volume Wearable Injectors Global Large Volume Wearable Injectors Sales by Region: 2018-2029

3.2.1 Global Large Volume Wearable Injectors Sales by Region: 2018-2023

3.2.2 Global Large Volume Wearable Injectors Sales by Region: 2024-2029

3.3 Global Large Volume Wearable Injectors Global Large Volume Wearable Injectors Revenue by Region: 2018-2029

3.3.1 Global Large Volume Wearable Injectors Revenue by Region: 2018-2023

3.3.2 Global Large Volume Wearable Injectors Revenue by Region: 2024-2029

3.4 North America Large Volume Wearable Injectors Market Facts & Figures by Country

3.4.1 North America Large Volume Wearable Injectors Market Size by Country: 2018 VS 2022 VS 2029

3.4.2 North America Large Volume Wearable Injectors Sales by Country (2018-2029)

3.4.3 North America Large Volume Wearable Injectors Revenue by Country (2018-2029)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Large Volume Wearable Injectors Market Facts & Figures by Country

3.5.1 Europe Large Volume Wearable Injectors Market Size by Country: 2018 VS 2022 VS 2029

3.5.2 Europe Large Volume Wearable Injectors Sales by Country (2018-2029)

3.5.3 Europe Large Volume Wearable Injectors Revenue by Country (2018-2029)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Large Volume Wearable Injectors Market Facts & Figures by Country

3.6.1 Asia Pacific Large Volume Wearable Injectors Market Size by Country: 2018 VS 2022 VS 2029

3.6.2 Asia Pacific Large Volume Wearable Injectors Sales by Country (2018-2029)

3.6.3 Asia Pacific Large Volume Wearable Injectors Revenue by Country (2018-2029)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.7 Latin America Large Volume Wearable Injectors Market Facts & Figures by Country

3.7.1 Latin America Large Volume Wearable Injectors Market Size by Country: 2018 VS 2022 VS 2029

3.7.2 Latin America Large Volume Wearable Injectors Sales by Country (2018-2029)

3.7.3 Latin America Large Volume Wearable Injectors Revenue by Country (2018-2029)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Large Volume Wearable Injectors Market Facts & Figures by Country

3.8.1 Middle East and Africa Large Volume Wearable Injectors Market Size by Country: 2018 VS 2022 VS 2029

3.8.2 Middle East and Africa Large Volume Wearable Injectors Sales by Country (2018-2029)

3.8.3 Middle East and Africa Large Volume Wearable Injectors Revenue by Country (2018-2029)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4.1 Global Large Volume Wearable Injectors Sales by Type (2018-2029)

4.1.1 Global Large Volume Wearable Injectors Sales by Type (2018-2023)

4.1.2 Global Large Volume Wearable Injectors Sales by Type (2024-2029)

4.1.3 Global Large Volume Wearable Injectors Sales Market Share by Type (2018-2029)

4.2 Global Large Volume Wearable Injectors Revenue by Type (2018-2029)

4.2.1 Global Large Volume Wearable Injectors Revenue by Type (2018-2023)

4.2.2 Global Large Volume Wearable Injectors Revenue by Type (2024-2029)

4.2.3 Global Large Volume Wearable Injectors Revenue Market Share by Type (2018-2029)

4.3 Global Large Volume Wearable Injectors Price by Type (2018-2029)

5.1 Global Large Volume Wearable Injectors Sales by Application (2018-2029)

5.1.1 Global Large Volume Wearable Injectors Sales by Application (2018-2023)

5.1.2 Global Large Volume Wearable Injectors Sales by Application (2024-2029)

5.1.3 Global Large Volume Wearable Injectors Sales Market Share by Application (2018-2029)

5.2 Global Large Volume Wearable Injectors Revenue by Application (2018-2029)

5.2.1 Global Large Volume Wearable Injectors Revenue by Application (2018-2023)

5.2.2 Global Large Volume Wearable Injectors Revenue by Application (2024-2029)

5.2.3 Global Large Volume Wearable Injectors Revenue Market Share by Application (2018-2029)

5.3 Global Large Volume Wearable Injectors Price by Application (2018-2029)

6.1 West Pharmaceuticals

6.1.1 West Pharmaceuticals Corporation Information

6.1.2 West Pharmaceuticals Description and Business Overview

6.1.3 West Pharmaceuticals Large Volume Wearable Injectors Sales, Revenue and Gross Margin (2018-2023)

6.1.4 West Pharmaceuticals Large Volume Wearable Injectors Product Portfolio

6.1.5 West Pharmaceuticals Recent Developments/Updates

6.2 Unilife Corporation

6.2.1 Unilife Corporation Corporation Information

6.2.2 Unilife Corporation Description and Business Overview

6.2.3 Unilife Corporation Large Volume Wearable Injectors Sales, Revenue and Gross Margin (2018-2023)

6.2.4 Unilife Corporation Large Volume Wearable Injectors Product Portfolio

6.2.5 Unilife Corporation Recent Developments/Updates

6.3 CeQur

6.3.1 CeQur Corporation Information

6.3.2 CeQur Description and Business Overview

6.3.3 CeQur Large Volume Wearable Injectors Sales, Revenue and Gross Margin (2018-2023)

6.3.4 CeQur Large Volume Wearable Injectors Product Portfolio

6.3.5 CeQur Recent Developments/Updates

6.4 Sensile Medical AG

6.4.1 Sensile Medical AG Corporation Information

6.4.2 Sensile Medical AG Description and Business Overview

6.4.3 Sensile Medical AG Large Volume Wearable Injectors Sales, Revenue and Gross Margin (2018-2023)

6.4.4 Sensile Medical AG Large Volume Wearable Injectors Product Portfolio

6.4.5 Sensile Medical AG Recent Developments/Updates

6.5 BD Medical

6.5.1 BD Medical Corporation Information

6.5.2 BD Medical Description and Business Overview

6.5.3 BD Medical Large Volume Wearable Injectors Sales, Revenue and Gross Margin (2018-2023)

6.5.4 BD Medical Large Volume Wearable Injectors Product Portfolio

6.5.5 BD Medical Recent Developments/Updates

6.6 Enable Injections

6.6.1 Enable Injections Corporation Information

6.6.2 Enable Injections Description and Business Overview

6.6.3 Enable Injections Large Volume Wearable Injectors Sales, Revenue and Gross Margin (2018-2023)

6.6.4 Enable Injections Large Volume Wearable Injectors Product Portfolio

6.6.5 Enable Injections Recent Developments/Updates

6.7 Roche Laboratories

6.6.1 Roche Laboratories Corporation Information

6.6.2 Roche Laboratories Description and Business Overview

6.6.3 Roche Laboratories Large Volume Wearable Injectors Sales, Revenue and Gross Margin (2018-2023)

6.4.4 Roche Laboratories Large Volume Wearable Injectors Product Portfolio

6.7.5 Roche Laboratories Recent Developments/Updates

6.8 scPharmaceuticals

6.8.1 scPharmaceuticals Corporation Information

6.8.2 scPharmaceuticals Description and Business Overview

6.8.3 scPharmaceuticals Large Volume Wearable Injectors Sales, Revenue and Gross Margin (2018-2023)

6.8.4 scPharmaceuticals Large Volume Wearable Injectors Product Portfolio

6.8.5 scPharmaceuticals Recent Developments/Updates

6.9 SteadyMed Therapeutics

6.9.1 SteadyMed Therapeutics Corporation Information

6.9.2 SteadyMed Therapeutics Description and Business Overview

6.9.3 SteadyMed Therapeutics Large Volume Wearable Injectors Sales, Revenue and Gross Margin (2018-2023)

6.9.4 SteadyMed Therapeutics Large Volume Wearable Injectors Product Portfolio

6.9.5 SteadyMed Therapeutics Recent Developments/Updates

6.10 Johnson & Johnson

6.10.1 Johnson & Johnson Corporation Information

6.10.2 Johnson & Johnson Description and Business Overview

6.10.3 Johnson & Johnson Large Volume Wearable Injectors Sales, Revenue and Gross Margin (2018-2023)

6.10.4 Johnson & Johnson Large Volume Wearable Injectors Product Portfolio

6.10.5 Johnson & Johnson Recent Developments/Updates

7.1 Large Volume Wearable Injectors Industry Chain Analysis

7.2 Large Volume Wearable Injectors Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Large Volume Wearable Injectors Production Mode & Process

7.4 Large Volume Wearable Injectors Sales and Marketing

7.4.1 Large Volume Wearable Injectors Sales Channels

7.4.2 Large Volume Wearable Injectors Distributors

7.5 Large Volume Wearable Injectors Customers

8.1 Large Volume Wearable Injectors Industry Trends

8.2 Large Volume Wearable Injectors Market Drivers

8.3 Large Volume Wearable Injectors Market Challenges

8.4 Large Volume Wearable Injectors Market Restraints

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

List of Tables

    Table 1. Global Large Volume Wearable Injectors Market Value Comparison by Type (2023-2029) & (US$ Million)

    Table 2. Global Large Volume Wearable Injectors Market Value Comparison by Application (2023-2029) & (US$ Million)

    Table 3. Global Large Volume Wearable Injectors Market Competitive Situation by Manufacturers in 2022

    Table 4. Global Large Volume Wearable Injectors Sales (K Units) of Key Manufacturers (2018-2023)

    Table 5. Global Large Volume Wearable Injectors Sales Market Share by Manufacturers (2018-2023)

    Table 6. Global Large Volume Wearable Injectors Revenue (US$ Million) by Manufacturers (2018-2023)

    Table 7. Global Large Volume Wearable Injectors Revenue Share by Manufacturers (2018-2023)

    Table 8. Global Market Large Volume Wearable Injectors Average Price (USD/Unit) of Key Manufacturers (2018-2023)

    Table 9. Global Key Players of Large Volume Wearable Injectors, Industry Ranking, 2021 VS 2022 VS 2023

    Table 10. Global Key Manufacturers of Large Volume Wearable Injectors, Manufacturing Sites & Headquarters

    Table 11. Global Key Manufacturers of Large Volume Wearable Injectors, Product Type & Application

    Table 12. Global Key Manufacturers of Large Volume Wearable Injectors, Date of Enter into This Industry

    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

    Table 14. Global Large Volume Wearable Injectors by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Large Volume Wearable Injectors as of 2022)

    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

    Table 16. Global Large Volume Wearable Injectors Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 17. Global Large Volume Wearable Injectors Sales by Region (2018-2023) & (K Units)

    Table 18. Global Large Volume Wearable Injectors Sales Market Share by Region (2018-2023)

    Table 19. Global Large Volume Wearable Injectors Sales by Region (2024-2029) & (K Units)

    Table 20. Global Large Volume Wearable Injectors Sales Market Share by Region (2024-2029)

    Table 21. Global Large Volume Wearable Injectors Revenue by Region (2018-2023) & (US$ Million)

    Table 22. Global Large Volume Wearable Injectors Revenue Market Share by Region (2018-2023)

    Table 23. Global Large Volume Wearable Injectors Revenue by Region (2024-2029) & (US$ Million)

    Table 24. Global Large Volume Wearable Injectors Revenue Market Share by Region (2024-2029)

    Table 25. North America Large Volume Wearable Injectors Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 26. North America Large Volume Wearable Injectors Sales by Country (2018-2023) & (K Units)

    Table 27. North America Large Volume Wearable Injectors Sales by Country (2024-2029) & (K Units)

    Table 28. North America Large Volume Wearable Injectors Revenue by Country (2018-2023) & (US$ Million)

    Table 29. North America Large Volume Wearable Injectors Revenue by Country (2024-2029) & (US$ Million)

    Table 30. Europe Large Volume Wearable Injectors Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 31. Europe Large Volume Wearable Injectors Sales by Country (2018-2023) & (K Units)

    Table 32. Europe Large Volume Wearable Injectors Sales by Country (2024-2029) & (K Units)

    Table 33. Europe Large Volume Wearable Injectors Revenue by Country (2018-2023) & (US$ Million)

    Table 34. Europe Large Volume Wearable Injectors Revenue by Country (2024-2029) & (US$ Million)

    Table 35. Asia Pacific Large Volume Wearable Injectors Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)

    Table 36. Asia Pacific Large Volume Wearable Injectors Sales by Region (2018-2023) & (K Units)

    Table 37. Asia Pacific Large Volume Wearable Injectors Sales by Region (2024-2029) & (K Units)

    Table 38. Asia Pacific Large Volume Wearable Injectors Revenue by Region (2018-2023) & (US$ Million)

    Table 39. Asia Pacific Large Volume Wearable Injectors Revenue by Region (2024-2029) & (US$ Million)

    Table 40. Latin America Large Volume Wearable Injectors Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 41. Latin America Large Volume Wearable Injectors Sales by Country (2018-2023) & (K Units)

    Table 42. Latin America Large Volume Wearable Injectors Sales by Country (2024-2029) & (K Units)

    Table 43. Latin America Large Volume Wearable Injectors Revenue by Country (2018-2023) & (US$ Million)

    Table 44. Latin America Large Volume Wearable Injectors Revenue by Country (2024-2029) & (US$ Million)

    Table 45. Middle East & Africa Large Volume Wearable Injectors Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 46. Middle East & Africa Large Volume Wearable Injectors Sales by Country (2018-2023) & (K Units)

    Table 47. Middle East & Africa Large Volume Wearable Injectors Sales by Country (2024-2029) & (K Units)

    Table 48. Middle East & Africa Large Volume Wearable Injectors Revenue by Country (2018-2023) & (US$ Million)

    Table 49. Middle East & Africa Large Volume Wearable Injectors Revenue by Country (2024-2029) & (US$ Million)

    Table 50. Global Large Volume Wearable Injectors Sales (K Units) by Type (2018-2023)

    Table 51. Global Large Volume Wearable Injectors Sales (K Units) by Type (2024-2029)

    Table 52. Global Large Volume Wearable Injectors Sales Market Share by Type (2018-2023)

    Table 53. Global Large Volume Wearable Injectors Sales Market Share by Type (2024-2029)

    Table 54. Global Large Volume Wearable Injectors Revenue (US$ Million) by Type (2018-2023)

    Table 55. Global Large Volume Wearable Injectors Revenue (US$ Million) by Type (2024-2029)

    Table 56. Global Large Volume Wearable Injectors Revenue Market Share by Type (2018-2023)

    Table 57. Global Large Volume Wearable Injectors Revenue Market Share by Type (2024-2029)

    Table 58. Global Large Volume Wearable Injectors Price (USD/Unit) by Type (2018-2023)

    Table 59. Global Large Volume Wearable Injectors Price (USD/Unit) by Type (2024-2029)

    Table 60. Global Large Volume Wearable Injectors Sales (K Units) by Application (2018-2023)

    Table 61. Global Large Volume Wearable Injectors Sales (K Units) by Application (2024-2029)

    Table 62. Global Large Volume Wearable Injectors Sales Market Share by Application (2018-2023)

    Table 63. Global Large Volume Wearable Injectors Sales Market Share by Application (2024-2029)

    Table 64. Global Large Volume Wearable Injectors Revenue (US$ Million) by Application (2018-2023)

    Table 65. Global Large Volume Wearable Injectors Revenue (US$ Million) by Application (2024-2029)

    Table 66. Global Large Volume Wearable Injectors Revenue Market Share by Application (2018-2023)

    Table 67. Global Large Volume Wearable Injectors Revenue Market Share by Application (2024-2029)

    Table 68. Global Large Volume Wearable Injectors Price (USD/Unit) by Application (2018-2023)

    Table 69. Global Large Volume Wearable Injectors Price (USD/Unit) by Application (2024-2029)

    Table 70. West Pharmaceuticals Corporation Information

    Table 71. West Pharmaceuticals Description and Business Overview

    Table 72. West Pharmaceuticals Large Volume Wearable Injectors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 73. West Pharmaceuticals Large Volume Wearable Injectors Product

    Table 74. West Pharmaceuticals Recent Developments/Updates

    Table 75. Unilife Corporation Corporation Information

    Table 76. Unilife Corporation Description and Business Overview

    Table 77. Unilife Corporation Large Volume Wearable Injectors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 78. Unilife Corporation Large Volume Wearable Injectors Product

    Table 79. Unilife Corporation Recent Developments/Updates

    Table 80. CeQur Corporation Information

    Table 81. CeQur Description and Business Overview

    Table 82. CeQur Large Volume Wearable Injectors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 83. CeQur Large Volume Wearable Injectors Product

    Table 84. CeQur Recent Developments/Updates

    Table 85. Sensile Medical AG Corporation Information

    Table 86. Sensile Medical AG Description and Business Overview

    Table 87. Sensile Medical AG Large Volume Wearable Injectors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 88. Sensile Medical AG Large Volume Wearable Injectors Product

    Table 89. Sensile Medical AG Recent Developments/Updates

    Table 90. BD Medical Corporation Information

    Table 91. BD Medical Description and Business Overview

    Table 92. BD Medical Large Volume Wearable Injectors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 93. BD Medical Large Volume Wearable Injectors Product

    Table 94. BD Medical Recent Developments/Updates

    Table 95. Enable Injections Corporation Information

    Table 96. Enable Injections Description and Business Overview

    Table 97. Enable Injections Large Volume Wearable Injectors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 98. Enable Injections Large Volume Wearable Injectors Product

    Table 99. Enable Injections Recent Developments/Updates

    Table 100. Roche Laboratories Corporation Information

    Table 101. Roche Laboratories Description and Business Overview

    Table 102. Roche Laboratories Large Volume Wearable Injectors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 103. Roche Laboratories Large Volume Wearable Injectors Product

    Table 104. Roche Laboratories Recent Developments/Updates

    Table 105. scPharmaceuticals Corporation Information

    Table 106. scPharmaceuticals Description and Business Overview

    Table 107. scPharmaceuticals Large Volume Wearable Injectors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 108. scPharmaceuticals Large Volume Wearable Injectors Product

    Table 109. scPharmaceuticals Recent Developments/Updates

    Table 110. SteadyMed Therapeutics Corporation Information

    Table 111. SteadyMed Therapeutics Description and Business Overview

    Table 112. SteadyMed Therapeutics Large Volume Wearable Injectors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 113. SteadyMed Therapeutics Large Volume Wearable Injectors Product

    Table 114. SteadyMed Therapeutics Recent Developments/Updates

    Table 115. Johnson & Johnson Corporation Information

    Table 116. Johnson & Johnson Description and Business Overview

    Table 117. Johnson & Johnson Large Volume Wearable Injectors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 118. Johnson & Johnson Large Volume Wearable Injectors Product

    Table 119. Johnson & Johnson Recent Developments/Updates

    Table 120. Key Raw Materials Lists

    Table 121. Raw Materials Key Suppliers Lists

    Table 122. Large Volume Wearable Injectors Distributors List

    Table 123. Large Volume Wearable Injectors Customers List

    Table 124. Large Volume Wearable Injectors Market Trends

    Table 125. Large Volume Wearable Injectors Market Drivers

    Table 126. Large Volume Wearable Injectors Market Challenges

    Table 127. Large Volume Wearable Injectors Market Restraints

    Table 128. Research Programs/Design for This Report

    Table 129. Key Data Information from Secondary Sources

    Table 130. Key Data Information from Primary Sources

List of Figures

    Figure 1. Product Picture of Large Volume Wearable Injectors

    Figure 2. Global Large Volume Wearable Injectors Market Value Comparison by Type (2023-2029) & (US$ Million)

    Figure 3. Global Large Volume Wearable Injectors Market Share by Type in 2022 & 2029

    Figure 4. Electronical Injectors Product Picture

    Figure 5. Mechanical Injectors Product Picture

    Figure 6. Others Product Picture

    Figure 7. Global Large Volume Wearable Injectors Market Value Comparison by Application (2023-2029) & (US$ Million)

    Figure 8. Global Large Volume Wearable Injectors Market Share by Application in 2022 & 2029

    Figure 9. Cancer Treatment

    Figure 10. Auto-immune Treatment

    Figure 11. Blood Disorders Treatment

    Figure 12. Others

    Figure 13. Global Large Volume Wearable Injectors Revenue, (US$ Million), 2018 VS 2022 VS 2029

    Figure 14. Global Large Volume Wearable Injectors Market Size (2018-2029) & (US$ Million)

    Figure 15. Global Large Volume Wearable Injectors Sales (2018-2029) & (K Units)

    Figure 16. Global Large Volume Wearable Injectors Average Price (USD/Unit) & (2018-2029)

    Figure 17. Large Volume Wearable Injectors Report Years Considered

    Figure 18. Large Volume Wearable Injectors Sales Share by Manufacturers in 2022

    Figure 19. Global Large Volume Wearable Injectors Revenue Share by Manufacturers in 2022

    Figure 20. The Global 5 and 10 Largest Large Volume Wearable Injectors Players: Market Share by Revenue in 2022

    Figure 21. Large Volume Wearable Injectors Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022

    Figure 22. Global Large Volume Wearable Injectors Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Figure 23. North America Large Volume Wearable Injectors Sales Market Share by Country (2018-2029)

    Figure 24. North America Large Volume Wearable Injectors Revenue Market Share by Country (2018-2029)

    Figure 25. U.S. Large Volume Wearable Injectors Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 26. Canada Large Volume Wearable Injectors Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 27. Europe Large Volume Wearable Injectors Sales Market Share by Country (2018-2029)

    Figure 28. Europe Large Volume Wearable Injectors Revenue Market Share by Country (2018-2029)

    Figure 29. Germany Large Volume Wearable Injectors Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 30. France Large Volume Wearable Injectors Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 31. U.K. Large Volume Wearable Injectors Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 32. Italy Large Volume Wearable Injectors Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 33. Russia Large Volume Wearable Injectors Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 34. Asia Pacific Large Volume Wearable Injectors Sales Market Share by Region (2018-2029)

    Figure 35. Asia Pacific Large Volume Wearable Injectors Revenue Market Share by Region (2018-2029)

    Figure 36. China Large Volume Wearable Injectors Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 37. Japan Large Volume Wearable Injectors Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 38. South Korea Large Volume Wearable Injectors Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 39. India Large Volume Wearable Injectors Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 40. Australia Large Volume Wearable Injectors Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 41. China Taiwan Large Volume Wearable Injectors Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 42. Indonesia Large Volume Wearable Injectors Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 43. Thailand Large Volume Wearable Injectors Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 44. Malaysia Large Volume Wearable Injectors Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 45. Latin America Large Volume Wearable Injectors Sales Market Share by Country (2018-2029)

    Figure 46. Latin America Large Volume Wearable Injectors Revenue Market Share by Country (2018-2029)

    Figure 47. Mexico Large Volume Wearable Injectors Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 48. Brazil Large Volume Wearable Injectors Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 49. Argentina Large Volume Wearable Injectors Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 50. Middle East & Africa Large Volume Wearable Injectors Sales Market Share by Country (2018-2029)

    Figure 51. Middle East & Africa Large Volume Wearable Injectors Revenue Market Share by Country (2018-2029)

    Figure 52. Turkey Large Volume Wearable Injectors Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 53. Saudi Arabia Large Volume Wearable Injectors Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 54. UAE Large Volume Wearable Injectors Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 55. Global Sales Market Share of Large Volume Wearable Injectors by Type (2018-2029)

    Figure 56. Global Revenue Market Share of Large Volume Wearable Injectors by Type (2018-2029)

    Figure 57. Global Large Volume Wearable Injectors Price (USD/Unit) by Type (2018-2029)

    Figure 58. Global Sales Market Share of Large Volume Wearable Injectors by Application (2018-2029)

    Figure 59. Global Revenue Market Share of Large Volume Wearable Injectors by Application (2018-2029)

    Figure 60. Global Large Volume Wearable Injectors Price (USD/Unit) by Application (2018-2029)

    Figure 61. Large Volume Wearable Injectors Value Chain

    Figure 62. Large Volume Wearable Injectors Production Process

    Figure 63. Channels of Distribution (Direct Vs Distribution)

    Figure 64. Distributors Profiles

    Figure 65. Bottom-up and Top-down Approaches for This Report

    Figure 66. Data Triangulation

    Figure 67. Key Executives Interviewed